Skip to content

The effect of agnogl on oligomenorrhea in polycystic ovary syndrome

Compare the effect of the drug agnogol and metformin on oligomenorrhea in patients with polycystic ovary syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015072623350N1
Enrollment
120
Registered
2015-09-08
Start date
2015-10-24
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oligomenorrhea. -

Interventions

Intervention 1: Intervention group 1:Agnogol drug contains extracts of five fingers prescription orally,3.2-4.8 mg 1 times daily After a meal, for 3 month. Intervention 2: In intervention group2: Met
Treatment - Drugs
Intervention group 1:Agnogol drug contains extracts of five fingers prescription orally,3.2-4.8 mg 1 times daily After a meal, for 3 month
In intervention group2: Metformin prescription orally,500 mg 3 times daily ( totally 1500 mg), for 3 month

Sponsors

Vice Chancellor for research, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: being married; Being pregnant; There oligomenorrhea; No known physical or mental illness confirmed by a psychiatrist; Not taking any hormonal medication to treat menstrual disorders in the last three months; No history of allergies to herbal medicines; No drugs affecting the menstrual cycle; Not taking anti-androgen drugs and combinations of estrogen and progesterone secretion and insulin action and insulin and drugs affecting between 1 month before the survey; No history of liver disease, kidney, cardiovascular, diabetes Exclusion criteria: taking any medications that affect the menstrual cycle; Allergy medication; Drugs and oral contraceptives; Androgen-secreting tumors, high blood prolactin; Unwillingness to cooperate in the project

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improve oligomenorrhea. Timepoint: Before, 3 months after intervention. Method of measurement: Check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArezoo.Shayan

Hamadan University of Medical Sciences

arezoo.shayan2012@yahoo.com; a.shayan@sums.ac.ir+98 813838551

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026